1I7G - Header Asymmetric Unit

HEADER TRANSCRIPTION 09-MAR-01 1I7G

TITLE CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN TITLE 2 PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-ALPHA; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562

KEYWDS ANTI PARALLEL HELIX SANDWICH, TRANSCRIPTION

EXPDTA X-RAY DIFFRACTION

AUTHOR J.F.W.PETERSEN,P.CRONET,R.FOLMER,N.BLOMBERG,K.SJOBLOM, AUTHOR 2 U.KARLSSON,E.-L.LINDSTEDT,K.BAMBERG

REVDAT 3 24-FEB-09 1I7G 1 VERSN REVDAT 2 01-APR-03 1I7G 1 JRNL REVDAT 1 09-MAR-02 1I7G 0

JRNL AUTH P.CRONET,J.F.PETERSEN,R.FOLMER,N.BLOMBERG, JRNL AUTH 2 K.SJOBLOM,U.KARLSSON,E.L.LINDSTEDT,K.BAMBERG JRNL TITL STRUCTURE OF THE PPARALPHA AND -GAMMA LIGAND JRNL TITL 2 BINDING DOMAIN IN COMPLEX WITH AZ 242; LIGAND JRNL TITL 3 SELECTIVITY AND AGONIST ACTIVATION IN THE PPAR JRNL TITL 4 FAMILY. JRNL REF STRUCTURE V. 9 699 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11587644 JRNL DOI 10.1016/S0969-2126(01)00634-7

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2276975.890 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 17852 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 868 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2768 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE : 0.3520 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 145 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2064 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.35000 REMARK 3 B22 (A**2) : 8.35000 REMARK 3 B33 (A**2) : -16.69000 REMARK 3 B12 (A**2) : 4.53000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.76 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.800 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.410 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.060 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.660 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PPARA.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : PPARA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1I7G COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAR-01. REMARK 100 THE RCSB ID CODE IS RCSB012999.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9465 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17036 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.36900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PDB ENTRY: 2PRG A MOLECULE REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM FORMATE, HEPES, DEOXY- REMARK 280 BIGCHAP, PH 6.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.53067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 67.06133 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 67.06133 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 33.53067 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 182 REMARK 465 SER A 183 REMARK 465 HIS A 184 REMARK 465 MET A 185 REMARK 465 SER A 186 REMARK 465 GLY A 187 REMARK 465 GLU A 188 REMARK 465 ASP A 189 REMARK 465 SER A 190 REMARK 465 GLU A 191 REMARK 465 THR A 192 REMARK 465 GLU A 193 REMARK 465 ALA A 194 REMARK 465 ASP A 195 REMARK 465 GLU A 196 REMARK 465 ASP A 197 REMARK 465 SER A 198 REMARK 465 LYS A 232 REMARK 465 ALA A 233 REMARK 465 VAL A 255 REMARK 465 ALA A 256 REMARK 465 LYS A 257 REMARK 465 LEU A 258 REMARK 465 VAL A 259 REMARK 465 ALA A 260 REMARK 465 ASN A 261 REMARK 465 GLY A 262 REMARK 465 ILE A 263

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 200 -28.75 -158.29 REMARK 500 LEU A 229 8.01 -69.19 REMARK 500 ASN A 236 92.31 61.94 REMARK 500 THR A 253 -1.16 -145.04 REMARK 500 ASN A 265 22.86 -145.87 REMARK 500 PRO A 295 119.46 -39.56 REMARK 500 LEU A 392 -64.03 -92.07 REMARK 500 REMARK 500 REMARK: NULL

REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CPQ A 470

REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 102 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 398 OE2 REMARK 620 2 LYS A 448 O 104.4 REMARK 620 3 GLU A 451 O 143.1 103.3 REMARK 620 4 GLU A 398 OE1 46.3 93.5 153.2 REMARK 620 N 1 2 3

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 102 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZ2 A 469 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CPQ A 470

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1I7I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN REMARK 900 PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242

DBREF 1I7G A 196 468 UNP Q07869 PPARA_HUMAN 196 468

SEQADV 1I7G GLY A 182 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G SER A 183 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G HIS A 184 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G MET A 185 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G SER A 186 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G GLY A 187 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G GLU A 188 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G ASP A 189 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G SER A 190 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G GLU A 191 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G THR A 192 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G GLU A 193 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G ALA A 194 UNP Q07869 CLONING ARTIFACT SEQADV 1I7G ASP A 195 UNP Q07869 CLONING ARTIFACT

SEQRES 1 A 287 GLY SER HIS MET SER GLY GLU ASP SER GLU THR GLU ALA SEQRES 2 A 287 ASP GLU ASP SER GLU THR ALA ASP LEU LYS SER LEU ALA SEQRES 3 A 287 LYS ARG ILE TYR GLU ALA TYR LEU LYS ASN PHE ASN MET SEQRES 4 A 287 ASN LYS VAL LYS ALA ARG VAL ILE LEU SER GLY LYS ALA SEQRES 5 A 287 SER ASN ASN PRO PRO PHE VAL ILE HIS ASP MET GLU THR SEQRES 6 A 287 LEU CYS MET ALA GLU LYS THR LEU VAL ALA LYS LEU VAL SEQRES 7 A 287 ALA ASN GLY ILE GLN ASN LYS GLU ALA GLU VAL ARG ILE SEQRES 8 A 287 PHE HIS CYS CYS GLN CYS THR SER VAL GLU THR VAL THR SEQRES 9 A 287 GLU LEU THR GLU PHE ALA LYS ALA ILE PRO GLY PHE ALA SEQRES 10 A 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 A 287 GLY VAL TYR GLU ALA ILE PHE ALA MET LEU SER SER VAL SEQRES 12 A 287 MET ASN LYS ASP GLY MET LEU VAL ALA TYR GLY ASN GLY SEQRES 13 A 287 PHE ILE THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO SEQRES 14 A 287 PHE CYS ASP ILE MET GLU PRO LYS PHE ASP PHE ALA MET SEQRES 15 A 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP ILE SER SEQRES 16 A 287 LEU PHE VAL ALA ALA ILE ILE CYS CYS GLY ASP ARG PRO SEQRES 17 A 287 GLY LEU LEU ASN VAL GLY HIS ILE GLU LYS MET GLN GLU SEQRES 18 A 287 GLY ILE VAL HIS VAL LEU ARG LEU HIS LEU GLN SER ASN SEQRES 19 A 287 HIS PRO ASP ASP ILE PHE LEU PHE PRO LYS LEU LEU GLN SEQRES 20 A 287 LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA SEQRES 21 A 287 GLN LEU VAL GLN ILE ILE LYS LYS THR GLU SER ASP ALA SEQRES 22 A 287 ALA LEU HIS PRO LEU LEU GLN GLU ILE TYR ARG ASP MET SEQRES 23 A 287 TYR

HET NA A 102 1 HET AZ2 A 469 28 HET CPQ A 470 25

HETNAM NA SODIUM ION HETNAM AZ2 (2S)-2-ETHOXY-3-[4-(2-{4-[(METHYLSULFONYL) HETNAM 2 AZ2 OXY]PHENYL}ETHOXY)PHENYL]PROPANOIC ACID HETNAM CPQ N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE

HETSYN AZ2 AZ 242 HETSYN CPQ DEOXY-BIGCHAP

FORMUL 2 NA NA 1+ FORMUL 3 AZ2 C20 H24 O7 S FORMUL 4 CPQ C42 H75 N3 O15 FORMUL 5 HOH *70(H2 O)

HELIX 1 1 THR A 200 PHE A 218 1 19 HELIX 2 2 ASN A 221 LEU A 229 1 9 HELIX 3 3 ASP A 243 LYS A 252 1 10 HELIX 4 4 GLU A 267 ALA A 293 1 27 HELIX 5 5 ASP A 301 SER A 322 1 22 HELIX 6 6 ALA A 333 GLY A 335 5 3 HELIX 7 7 ARG A 341 LEU A 347 1 7 HELIX 8 8 PRO A 350 ILE A 354 5 5 HELIX 9 9 MET A 355 ALA A 367 1 13 HELIX 10 10 ASP A 371 CYS A 384 1 14 HELIX 11 11 ASN A 393 HIS A 416 1 24 HELIX 12 12 PHE A 421 GLU A 451 1 31 HELIX 13 13 HIS A 457 TYR A 468 1 12

SHEET 1 A 4 PHE A 239 ILE A 241 0 SHEET 2 A 4 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241 SHEET 3 A 4 GLY A 329 VAL A 332 -1 O MET A 330 N ILE A 339 SHEET 4 A 4 MET A 325 ASN A 326 -1 N ASN A 326 O GLY A 329

LINK NA NA A 102 OE2 GLU A 398 1555 1555 2.54 LINK NA NA A 102 O LYS A 448 1555 3664 2.42 LINK NA NA A 102 O GLU A 451 1555 3664 2.46 LINK OE1 GLU A 398 NA NA A 102 1555 1555 2.97

CISPEP 1 LYS A 349 PRO A 350 0 1.67

SITE 1 AC1 5 GLU A 398 LYS A 448 GLU A 451 SER A 452 SITE 2 AC1 5 ALA A 454 SITE 1 AC2 15 ILE A 241 LEU A 247 PHE A 273 CYS A 275 SITE 2 AC2 15 CYS A 276 SER A 280 TYR A 314 MET A 330 SITE 3 AC2 15 VAL A 332 ILE A 339 MET A 355 HIS A 440 SITE 4 AC2 15 VAL A 444 LEU A 460 TYR A 464 SITE 1 AC3 6 LYS A 204 LYS A 208 ARG A 348 LEU A 410 SITE 2 AC3 6 HIS A 411 GLU A 451

CRYST1 76.968 76.968 100.592 90.00 90.00 120.00 P 31 2 1 6

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.012992 0.007501 0.000000 0.00000

SCALE2 0.000000 0.015002 0.000000 0.00000

SCALE3 0.000000 0.000000 0.009941 0.00000